CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells

Hye-yon Cho, Yong-Beom Kim, Wook-ha Park, Jae Hong No

Cancer Research and Treatment. 2021;53(3):819-828. Published online 2020 December 16 DOI: https://doi.org/10.4143/crt.2020.1013

Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells

Hye-yon Cho, Yong-Beom Kim, Wook-ha Park, Jae Hong No

Cancer Research and Treatment. 2021;53(3):819-828

Link1

Link2 Link3

Rucaparib: a novel PARP inhibitor for <em>BRCA</em> advanced ovarian cancer

Ilaria Colombo, Stephanie Lheureux, Amit Manulal Oza

Drug Design, Development and Therapy. 2018;Volume 12:605-617

Link1 Link2

P-057 Expression of the cyclin-dependent kinase inhibitor p21 is linkedto regulation of RAD51 in response to etoposide treatment of small cell lung cancer cells

R. Jensen, M. Spang-Thomsen, L. Hansen

Lung Cancer. 2005;49:S129

Link1 Link2

Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib

Cai M. Roberts, Mehida Rojas-Alexandre, Ruth E. Hanna, Z. Ping Lin, Elena S. Ratner

Cancers. 2023;15(15):3919

Link1

Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer

Sho Sato, Hirokazu Matsushita, Daisuke Shintani, Nao Fujieda, Akira Yabuno, Tadaaki Nishikawa, Keiichi Fujiwara, Kazuhiro Kakimi, Kosei Hasegawa

. 2022;

Link1 Link2

Transforming growth factor downregulates homologous recombination repair genes and increases PARP inhibitor sensitivity in BRCA2 wild-type epithelial ovarian cancer cells

M. Alexandre, Z.P. Lin, R.E. Hanna, E.S. Ratner

Gynecologic Oncology. 2018;149:69

Link1 Link2

Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer

Sho Sato, Hirokazu Matsushita, Daisuke Shintani, Yukari Kobayashi, Nao Fujieda, Akira Yabuno, Tadaaki Nishikawa, Keiichi Fujiwara, Kazuhiro Kakimi, Kosei Hasegawa

BMC Cancer. 2022;22(1):

Link1

Link2 Link3

Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer

Z. Ping Lin, Yong-Lian Zhu, Ying-Chun Lo, Jake Moscarelli, Amy Xiong, Yasmin Korayem, Pamela H. Huang, Smith Giri, Patricia LoRusso, Elena S. Ratner

PLOS ONE. 2018;13(11):e0207399

Link1

Rucaparib: A Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Ovarian Cancer

Donald C. Moore, J. Tanner Ringley, Jolly Patel

Journal of Pharmacy Practice. 2017;32(2):219-224

Link1 Link2 Link3

Checkpoint Kinase 1 Activation Enhances Intestinal Epithelial Barrier Function via Regulation of Claudin-5 Expression

Akihiro Watari, Maki Hasegawa, Kiyohito Yagi, Masuo Kondoh

PLOS ONE. 2016;11(1):e0145631

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.